Theravance Biopharma Inc (TBPH)

10:09 AM

Theravance Biopharma Inc. stock volume spike explainedTrend Reversal & Accurate Entry/Exit Alerts - newser.com

10:09 AM

08:27 AM

Can Theravance Biopharma Inc. stock deliver consistent earnings growth2025 Risk Factors & Safe Capital Allocation Plans - newser.com

08:27 AM

05:02 AM

Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com

05:02 AM

02:34 AM

Top chart patterns to watch in Theravance Biopharma Inc.Trade Volume Summary & Real-Time Buy Zone Alerts - newser.com

02:34 AM

01:39 AM

Will breakout in Theravance Biopharma Inc. lead to full recovery2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com

01:39 AM

12:43 PM

Leading vs lagging indicators on Theravance Biopharma Inc. performanceTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com

12:43 PM

Oct 12, 2025

Theravance Biopharma Hits New 52-Week High of $15.15, Up 67.59% - Markets Mojo

Oct 12, 2025

Oct 12, 2025

How to integrate Theravance Biopharma Inc. into portfolio analysis tools2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com

Oct 12, 2025

Oct 11, 2025

Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $23.00 - Defense World

Oct 11, 2025

Oct 10, 2025

Relative strength of Theravance Biopharma Inc. in sector analysisEarnings Recap Report & Entry Point Confirmation Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Is Theravance Biopharma Inc. (0TB) stock positioned for secular growthJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com

Oct 10, 2025

Oct 09, 2025

What analysts say about Theravance Biopharma Inc stockInsider Trading Compliance & Build Capital Safely - earlytimes.in

Oct 09, 2025

Oct 09, 2025

Theravance Biopharma (NASDAQ:TBPH) Earns "Hold (C)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Theravance Biopharma (NASDAQ:TBPH) Earns “Hold (C)” Rating from Weiss Ratings - Defense World

Oct 09, 2025

Oct 07, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Oct 07, 2025

Oct 06, 2025

Theravance Biopharma (NASDAQ:TBPH) Sets New 12-Month HighTime to Buy? - MarketBeat

Oct 06, 2025

Oct 06, 2025

Identifying reversal signals in Theravance Biopharma Inc.Weekly Stock Report & Daily Oversold Bounce Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

Published on: 2025-10-06 07:12:34 - newser.com

Oct 06, 2025

Oct 06, 2025

Can swing trading help recover from Theravance Biopharma Inc. lossesWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com

Oct 06, 2025

Oct 06, 2025

Will Theravance Biopharma Inc. benefit from macro trendsJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com

Oct 06, 2025

Oct 05, 2025

How to manage a losing position in Theravance Biopharma Inc.Watch List & Verified Short-Term Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Can Theravance Biopharma Inc. (0TB) stock double in coming years2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com

Oct 05, 2025

Oct 05, 2025

What insider purchases suggest about Theravance Biopharma Inc. (0TB) stockProduct Launch & Weekly High Conviction Ideas - newser.com

Oct 05, 2025

Oct 03, 2025

Published on: 2025-10-03 07:08:04 - newser.com

Oct 03, 2025

Oct 03, 2025

What RSI levels show for Theravance Biopharma Inc. (0TB) stock2025 Top Decliners & Risk Controlled Daily Plans - newser.com

Oct 03, 2025

Oct 02, 2025

Theravance Biopharma Inc. stock momentum explainedWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 02, 2025

Oct 02, 2025

Voya Investment Management LLC Reduces Stock Holdings in Theravance Biopharma, Inc. $TBPH - Defense World

Oct 02, 2025

Oct 01, 2025

Theravance Biopharma, Inc. $TBPH Shares Bought by Ballentine Partners LLC - Defense World

Oct 01, 2025

Oct 01, 2025

Theravance Biopharma Hits New 52-Week High of $14.87, Up 67.82% - Markets Mojo

Oct 01, 2025